These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 15451458)

  • 21. Engineering ex vivo-expanded marrow stromal cells to secrete calcitonin gene-related peptide using adenoviral vector.
    Deng W; Bivalacqua TJ; Chattergoon NN; Jeter JR; Kadowitz PJ
    Stem Cells; 2004; 22(7):1279-91. PubMed ID: 15579646
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preliminary study of mesenchymal stem cells-seeded type I collagen-glycosaminoglycan matrices for cartilage repair.
    Xiang Z; Hu W; Kong Q; Zhou H; Zhang X
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2006 Feb; 20(2):148-54. PubMed ID: 16529325
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of multipotent differentiation potentials of murine primary bone marrow stromal cells and mesenchymal stem cell line C3H10T1/2.
    Zhao L; Li G; Chan KM; Wang Y; Tang PF
    Calcif Tissue Int; 2009 Jan; 84(1):56-64. PubMed ID: 19052794
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Novel object recognition in Apoe(-/-) mice improved by neonatal implantation of wild-type multipotential stromal cells.
    Peister A; Zeitouni S; Pfankuch T; Reger RL; Prockop DJ; Raber J
    Exp Neurol; 2006 Sep; 201(1):266-9. PubMed ID: 16808914
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dexamethasone-induced adipogenesis in primary marrow stromal cell cultures: mechanism of steroid-induced osteonecrosis.
    Yin L; Li YB; Wang YS
    Chin Med J (Engl); 2006 Apr; 119(7):581-8. PubMed ID: 16620700
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genetic marking with the DeltaLNGFR-gene for tracing goat cells in bone tissue engineering.
    Kruyt MC; Stijns MM; Fedorovich NE; De Bruijn JD; Van Blitterswijk CA; Verbout AJ; Rozemuller H; Hagenbeek A; Dhert WJ; Martens AC
    J Orthop Res; 2004 Jul; 22(4):697-702. PubMed ID: 15183423
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Retroviral vector-producing mesenchymal stem cells for targeted suicide cancer gene therapy.
    Uchibori R; Okada T; Ito T; Urabe M; Mizukami H; Kume A; Ozawa K
    J Gene Med; 2009 May; 11(5):373-81. PubMed ID: 19274675
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [An experimental study on repairing bone defect with composite of beta-tricalcium phosphate-hyaluronic acid-type I collagen-marrow stromal cells].
    Wei A; Liu S; Peng H; Tao H
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2005 Jun; 19(6):468-72. PubMed ID: 16038466
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vascular endothelial growth factor gene-transferred bone marrow stromal cells engineered with a herpes simplex virus type 1 vector can improve neurological deficits and reduce infarction volume in rat brain ischemia.
    Miki Y; Nonoguchi N; Ikeda N; Coffin RS; Kuroiwa T; Miyatake S
    Neurosurgery; 2007 Sep; 61(3):586-94; discussion 594-5. PubMed ID: 17881973
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Matrix-mediated retention of adipogenic differentiation potential by human adult bone marrow-derived mesenchymal stem cells during ex vivo expansion.
    Mauney JR; Volloch V; Kaplan DL
    Biomaterials; 2005 Nov; 26(31):6167-75. PubMed ID: 15913765
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gene electro-transfer of an improved erythropoietin plasmid in mice and non-human primates.
    Fattori E; Cappelletti M; Zampaglione I; Mennuni C; Calvaruso F; Arcuri M; Rizzuto G; Costa P; Perretta G; Ciliberto G; La Monica N
    J Gene Med; 2005 Feb; 7(2):228-36. PubMed ID: 15515133
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bone marrow stromal cells as a genetic platform for systemic delivery of therapeutic proteins in vivo: human factor IX model.
    Krebsbach PH; Zhang K; Malik AK; Kurachi K
    J Gene Med; 2003 Jan; 5(1):11-7. PubMed ID: 12516047
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Baboon mesenchymal stem cells can be genetically modified to secrete human erythropoietin in vivo.
    Bartholomew A; Patil S; Mackay A; Nelson M; Buyaner D; Hardy W; Mosca J; Sturgeon C; Siatskas M; Mahmud N; Ferrer K; Deans R; Moseley A; Hoffman R; Devine SM
    Hum Gene Ther; 2001 Aug; 12(12):1527-41. PubMed ID: 11506695
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Engineered extracellular matrices modulate the expression profile and feeder properties of bone marrow-derived human multipotent mesenchymal stromal cells.
    Seib FP; Müller K; Franke M; Grimmer M; Bornhäuser M; Werner C
    Tissue Eng Part A; 2009 Oct; 15(10):3161-71. PubMed ID: 19358630
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Advances in gene expression of bone marrow stromal cells].
    Han B; Fu X; Sun X
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2005 Feb; 19(2):153-8. PubMed ID: 15759936
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A statistical pattern recognition approach for determining cellular viability and lineage phenotype in cultured cells and murine bone marrow.
    Quinn J; Fisher PW; Capocasale RJ; Achuthanandam R; Kam M; Bugelski PJ; Hrebien L
    Cytometry A; 2007 Aug; 71(8):612-24. PubMed ID: 17542025
    [TBL] [Abstract][Full Text] [Related]  

  • 37. DLX5 overexpression impairs osteogenic differentiation of human bone marrow stromal cells.
    Muraglia A; Perera M; Verardo S; Liu Y; Cancedda R; Quarto R; Corte G
    Eur J Cell Biol; 2008 Oct; 87(10):751-61. PubMed ID: 18620781
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vivo matrix production by bone marrow stromal cells seeded on PLGA scaffolds for ligament tissue engineering.
    van Eijk F; Saris DB; Fedorovich NE; Kruyt MC; Willems WJ; Verbout AJ; Martens AC; Dhert WJ; Creemers L
    Tissue Eng Part A; 2009 Oct; 15(10):3109-17. PubMed ID: 19338450
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chondrogenic differentiation of bovine bone marrow mesenchymal stem cells (MSCs) in different hydrogels: influence of collagen type II extracellular matrix on MSC chondrogenesis.
    Bosnakovski D; Mizuno M; Kim G; Takagi S; Okumura M; Fujinaga T
    Biotechnol Bioeng; 2006 Apr; 93(6):1152-63. PubMed ID: 16470881
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Correction of a mineralization defect by overexpression of a wild-type cDNA for COL1A1 in marrow stromal cells (MSCs) from a patient with osteogenesis imperfecta: a strategy for rescuing mutations that produce dominant-negative protein defects.
    Pochampally RR; Horwitz EM; DiGirolamo CM; Stokes DS; Prockop DJ
    Gene Ther; 2005 Jul; 12(14):1119-25. PubMed ID: 15815702
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.